Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

National Drug Code

Is NDC 65250-0266-20 recalled?

Exparel

Yes — this exact package was recalled

1 FDA recall names the code 65250-0266-20 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.

Active ingredient
bupivacaine
Strength
BUPIVACAINE 13.3 mg/mL
Form
Injection, Suspension, Liposomal · Infiltration
Labeler
Pacira Pharmaceuticals, Inc.
Type
Human Prescription Drug
Product code
65250-0266

Recalls naming this package

Class II ยท Moderate risk

Exparel

Sub Potent Drug: Out of Specification (OOS)

Terminated Wrong potency / content Pacira Pharmaceuticals, Inc. D-0621-2020

Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.

Other recalled products from this labeler